Acute XXXX in the Community.

@entity1 @entity1187 @entity301 @entity1459 @entity583 @entity204
OBJECTIVES: To measure the incidence of @entity1187 ( @entity1187 ), defined as first-ever @entity583 ( @entity583 ) or @entity1459 ( @entity1459 ); evaluate recent temporal trends; and determine whether survival after @entity1187 has changed over time and differs by type. @entity1 AND METHODS: This was a population surveillance study conducted in Olmsted County, Minnesota (population: 144,248). All @entity1 hospitalized with incident @entity1187 between January 1, 2005, and December 31, 2010, were identified using International Classification of Diseases, Ninth Revision codes, natural language processing of the medical records, and biomarkers. @entity583 was validated by epidemiologic criteria and @entity1459 by the Braunwald classification. @entity1 were followed through June 30, 2013, for @entity204 . RESULTS: Of 1244 incident @entity1187 cases, 35% (n=438) were @entity1459 and 65% (n=806) were @entity583 . The standardized rates (per 100,000) of @entity1187 were 284 (95% CI, 248-319) in 2005 and 184 (95% CI, 157-210) in 2010 (2010 vs 2005: rate ratio, 0.62; 95% CI, 0.53-0.73), indicating a 38% decline (similar for @entity583 and @entity1459 ). The 30-day case fatality rates did not differ by year of diagnosis but were worse for @entity583 (8.9%; 95% CI, 6.9%-10.9%) compared with @entity1459 (1.9%; 95% CI, 0.6%-3.1%). Among 30-day survivors, the risk of @entity204 did not differ by @entity1187 type or diagnosis year. CONCLUSION: In the community, @entity1459 constitutes 35% of @entity1187 . The incidence of @entity1187 has declined in recent years, and trends were similar for @entity1459 and @entity583 , reaffirming a substantial decline in all acute manifestations of @entity301 . Survival after @entity1187 did not change over time, but 30-day survival was worse for @entity583 compared with @entity1459 .
